Silexion Therapeutics Corp Warrant Share Price

Silexion Therapeutics Corp Warrant Share Price

NASDAQ: SLXNW | Micro Cap
$0.02
+$0.00 (27.86%) Last updated on 22 Oct, 2026 | 20:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Silexion Therapeutics Corp Warrant Stock Performance

Open
$0.02
Prev. Close
$0.01
Circuit Range
N/A
Day Range
$0.02 - $0.02
Year Range
$0.02 - $0.07
Volume
100
Average Traded
$0.02

Silexion Therapeutics Corp Warrant Share Price Today

As of 31 October 2026, Silexion Therapeutics Corp Warrant's share price is $0.02. The stock opened at $0.02, compared to its previous close of $0.01. During today's trading session, Silexion Therapeutics Corp Warrant's share price traded between $0.02 and $0.02, with an average price of $0.02. Over the past 52 weeks, the stock has recorded a high of $0.07 and a low of $0.02. In terms of performance, Silexion Therapeutics Corp Warrant's share price has declined by 55.25% over the last six months and is down 45.76% on a year-on-year basis.

Silexion Therapeutics Corp Warrant Share Price Chart

$0.02$0.02
L
Show Current Price
H

Silexion Therapeutics Corp Warrant Stock Fundamentals & Key Indicators

Market Cap
$23798.32
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Silexion Therapeutics Corp Warrant

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.

Silexion Therapeutics Corp Warrant Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.02
$0.02
-63.04%
Jul 2026
$0.04
$0.05
+4.55%
Jun 2026
$0.05
$0.04
-38.03%
Dec 2025
$0.07
$0.07
+136.67%
Aug 2025
$0.04
$0.03
-28.57%
Jul 2025
$0.04
$0.04
+5.00%
Jun 2025
$0.05
$0.04
-18.37%
May 2025
$0.06
$0.05
-12.50%
Apr 2025
$0.08
$0.06
-26.32%
Mar 2025
$0.07
$0.08
+26.67%
Feb 2025
$0.08
$0.06
-27.71%
Jan 2025
$0.03
$0.08
+151.52%

SLXNW Share Price FAQs